REGULATION OF THE (POLY) SIALIC ACID VIRULENCE FACTOR
(聚)唾液酸毒力因子的调节
基本信息
- 批准号:2887612
- 负责人:
- 金额:$ 15.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-07-01 至 2003-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broad objective of this proposal is to increase our understanding
of bacterial polysaccharide synthesis in pathogenic microorganisms. The
K1 antigen, or polysialic acid capsule is a homopolymer of alpha2,8-
linked sialyl residues. Synthesis of the capsule depends on about 15
genes of the kps pathogenicity locus that is organized into at least two
convergently transcribed operons, one of which is controlled by the
thermoregulated kpsF promoter. The anti-recognition functions of sialic
acids (anti-phagocytosis; inhibition of antibody-independent complement
fixation; molecular mimicry of host antigens) make these unique nine-
carbon carboxy sugar acids important determinants of virulence in
diverse human and animal pathogens. Escherichia coli K1 is a leading
cause of neonatal meningitis and a frequent cause of urinary tract
infections in children and bacteremia in adults. Vaccination against
these diseases may not always be practical, and conventional drug
therapy is problematic. Alternative or improved therapies may emerge
from a better understanding of capsular polysaccharide expression.
Objectives of the application are to understand the molecular mechanisms
of capsule thermoregulation and sialic acid precursor biosynthesis.
This information is necessary for construction of defined mutants that
will allow us to unambiguously determine the association between capsule
and lipopolysaccharide O antigen during disease. To accomplish these
objectives, we will pursue three specific aims. First, thermoregulation
will be investigated with an in vitro transcription system designed to
determine the intrinsic sensitivity of the kpsF promoter to temperature.
The role of a positive regulator will be determined by isolation and
characterization of mutants that no longer regulate the kpsF promoter.
Second, the origin of sialic acid biosynthetic precursor, N-
acetylmannosamine, will be determined by genetic and biochemical
approaches. Finally, the role of the capsule and its association with
O antigen will be determined using defined mutants in an animal model
of E. coli K1 meningitis and bacteremia. At the completion of this
research, we expect to have clearly delineated the relative
contributions of cell surface polysaccharides to pathogenesis. We also
expect to have identified specific new targets for potential therapeutic
developments aimed at blocking capsule expression in vivo.
这项建议的主要目标是增进我们对
病原微生物中细菌多糖的合成。 的
K1抗原或聚唾液酸胶囊是α 2,8-
连接的唾液酸残基。 胶囊的合成取决于约15
KPS致病性基因座的基因,其被组织成至少两个
聚合转录操纵子,其中之一是由
温度调节的kpsF启动子。 唾液酸的抗识别功能
酸(抗吞噬作用;抑制抗体非依赖性补体
固定;宿主抗原的分子模拟)使这些独特的九-
碳羧基糖酸是毒力的重要决定因素
多种人类和动物病原体。 大肠杆菌K1是一种主要的
引起新生儿脑膜炎和泌尿道疾病的常见原因
儿童感染和成人菌血症。疫苗接种
这些疾病可能并不总是实用的,
治疗是有问题的。 可能会出现替代或改进的治疗方法
从更好地了解荚膜多糖的表达。
应用程序的目标是了解分子机制
囊体温度调节和唾液酸前体生物合成。
这些信息对于构建确定的突变体是必要的,
将使我们能够明确地确定胶囊
和脂多糖O抗原。 完成这些
我们将努力实现三个具体目标。第一,体温调节
将使用体外转录系统进行研究,该系统旨在
确定kpsF启动子对温度的固有敏感性。
正调节剂的作用将由隔离和
表征不再调节kpsF启动子的突变体。
第二,唾液酸生物合成前体N-
乙酰甘露糖胺,将由遗传和生化
接近。 最后,胶囊的作用及其与
将使用动物模型中确定的突变体测定O抗原
大肠coli K1脑膜炎和菌血症。 在完成此
研究,我们希望能清楚地描绘出相对的
细胞表面多糖对发病机制的贡献。 我们也
我希望已经确定了潜在治疗的特定新靶点,
旨在体内阻断胶囊表达的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric Ross Vimr其他文献
Eric Ross Vimr的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric Ross Vimr', 18)}}的其他基金
REGULATION OF THE (POLY) SIALIC ACID VIRULENCE FACTOR
(聚)唾液酸毒力因子的调节
- 批准号:
2677806 - 财政年份:1998
- 资助金额:
$ 15.92万 - 项目类别:
REGULATION OF THE (POLY) SIALIC ACID VIRULENCE FACTOR
(聚)唾液酸毒力因子的调节
- 批准号:
6170729 - 财政年份:1998
- 资助金额:
$ 15.92万 - 项目类别:
REGULATION OF THE (POLY) SIALIC ACID VIRULENCE FACTOR
(聚)唾液酸毒力因子的调节
- 批准号:
6510754 - 财政年份:1998
- 资助金额:
$ 15.92万 - 项目类别:
Regulation of the (poly) sialic virulence factor
(多)唾液酸毒力因子的调节
- 批准号:
7000377 - 财政年份:1998
- 资助金额:
$ 15.92万 - 项目类别:
Regulation of the (poly) sialic virulence factor
(多)唾液酸毒力因子的调节
- 批准号:
7330497 - 财政年份:1998
- 资助金额:
$ 15.92万 - 项目类别:
Regulation of the (poly) sialic virulence factor
(多)唾液酸毒力因子的调节
- 批准号:
6838179 - 财政年份:1998
- 资助金额:
$ 15.92万 - 项目类别:
Regulation of the (poly) sialic virulence factor
(多)唾液酸毒力因子的调节
- 批准号:
6702853 - 财政年份:1998
- 资助金额:
$ 15.92万 - 项目类别:
相似海外基金
Metal binding characteristics of bacterial capsules
细菌荚膜的金属结合特性
- 批准号:
41822-1991 - 财政年份:1993
- 资助金额:
$ 15.92万 - 项目类别:
Discovery Grants Program - Individual
Metal binding characteristics of bacterial capsules
细菌荚膜的金属结合特性
- 批准号:
41822-1991 - 财政年份:1992
- 资助金额:
$ 15.92万 - 项目类别:
Discovery Grants Program - Individual
Metal binding characteristics of bacterial capsules
细菌荚膜的金属结合特性
- 批准号:
41822-1991 - 财政年份:1991
- 资助金额:
$ 15.92万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




